First Mercantile Trust’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$241K Sell
626
-724
-54% -$267K 0.03% 346
2021
Q2
$317K Sell
1,350
-561
-29% -$100K 0.04% 273
2021
Q1
$250K Buy
1,911
+581
+44% +$84.2K 0.03% 353
2020
Q4
$139K Buy
1,330
+9
+0.7% +$911 0.02% 579
2020
Q3
$103K Sell
1,321
-296
-18% -$20.6K 0.01% 666
2020
Q2
$104K Buy
+1,617
New +$88.6K 0.01% 647

Other funds holding MRNA

First Mercantile Trust's MRNA Position: Q3 2021 in Review

First Mercantile Trust reduced its Moderna (MRNA) stake by 54% in Q3 2021, selling an estimated $267K and leaving 626 shares worth $241K. The position accounts for 0.03% of the portfolio, ranked #346.

First Mercantile Trust first reported a position in MRNA in Q2 2020 and has held it in 6 quarters since. The position peaked at $317K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • First Mercantile Trust held 626 shares of Moderna worth $241K as of Q3 2021.
  • First Mercantile Trust sold 724 Moderna shares in Q3 2021, an estimated $267K.
  • Moderna made up 0.03% of First Mercantile Trust's portfolio in Q3 2021, its #346 holding.
  • First Mercantile Trust first reported a position in Moderna in Q2 2020 and has held it in 6 quarters since.
  • First Mercantile Trust's Moderna position peaked at $317K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.